Forbes January 5, 2024
This story is part of a series on the current progression in Regenerative Medicine. This piece discusses advances in brain-machine interfaces.
In 1999, I defined regenerative medicine as the collection of interventions that restore to normal function tissues and organs that have been damaged by disease, injured by trauma, or worn by time. I include a full spectrum of chemical, gene, and protein-based medicines, cell-based therapies, and biomechanical interventions that achieve that goal.
In the United States alone, roughly two million people are living with limb loss, the majority of whom deal with prosthetic limbs daily. Often cumbersome and imprecise, traditional prosthetic limbs are challenging to use effectively and fall well short of the functionality of the original limb. Even...
Today's Sponsors
Today's Sponsor